Administrative Coding in Electronic Health Care Record‐Based Research of NAFLD: An Expert Panel Consensus Statement
Hannes Hagström, Leon Anton Adams, Alina M. Allen et al. · Hepatology · 2021
BACKGROUND AND AIMS: Electronic health record (EHR)-based research allows the capture of large amounts of data, which is necessary in NAFLD, where the risk of clinical liver outcomes is generally low. The lack of consensus on which International Classification of Diseases (ICD) codes should be used as exposures and outcomes limits comparability and generalizability of results across studies. We aimed to establish consensus among a panel of experts on ICD codes that could become the reference standard and provide guidance around common methodological issues. APPROACH AND RESULTS: Researchers with an interest in EHR-based NAFLD research were invited to collectively define which administrative codes are most appropriate for documenting exposures and outcomes. We used a modified Delphi approach to reach consensus on several commonly encountered methodological challenges in the field. After two rounds of revision, a high level of agreement (>67%) was reached on all items considered. Full consensus was achieved on a comprehensive list of administrative codes to be considered for inclusion and exclusion criteria in defining exposures and outcomes in EHR-based NAFLD research. We also provide suggestions on how to approach commonly encountered methodological issues and identify areas for future research. CONCLUSIONS: This expert panel consensus statement can help harmonize and improve generalizability of EHR-based NAFLD research.
Cited by 259 works. doi:10.1002/hep.31726
Authors
- Hannes Hagström
- Leon Anton Adams
- Alina M. Allen
- Christopher D. Byrne
- Yoosoo Chang
- Henning Grønbæk
- Mona Hassan Ismail
- Peter Jepsen
- Fasiha Kanwal
- Jennifer R. Kramer
- Jeffrey Victor Lazarus
- Michelle T. Long
- Rohit Seth Loomba
- Philip Noel Newsome
- Ian A.C. Rowe
- Seungho Ryu
- Jörn Markus Schattenberg
- Marina Serper
- Nick Sheron
- Tracey G. Simon
References
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- Consensus development methods, and their use in clinical guideline development.
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- Defining consensus: A systematic review recommends methodologic criteria for reporting of Delphi studies
- Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up
- Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD
- The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years
- Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease
- Beyond randomized controlled trials: A critical comparison of trials with nonrandomized studies
- Prognosis of patients with a diagnosis of fatty liver--a registry-based cohort study.